205 related articles for article (PubMed ID: 34474252)
1. In-silico immunoinformatic analysis of SARS-CoV-2 virus for the development of putative vaccine construct.
Sharma A; Pal S; Panwar A; Kumar S; Kumar A
Immunobiology; 2021 Sep; 226(5):152134. PubMed ID: 34474252
[TBL] [Abstract][Full Text] [Related]
2. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
Yang Z; Bogdan P; Nazarian S
Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
[TBL] [Abstract][Full Text] [Related]
3. Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches.
Dong R; Chu Z; Yu F; Zha Y
Front Immunol; 2020; 11():1784. PubMed ID: 32849643
[TBL] [Abstract][Full Text] [Related]
4. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
Jakhar R; Kaushik S; Gakhar SK
J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
[TBL] [Abstract][Full Text] [Related]
5. A vaccine built from potential immunogenic pieces derived from the SARS-CoV-2 spike glycoprotein: A computational approximation.
Marchan J
J Immunol Methods; 2022 Mar; 502():113216. PubMed ID: 35007561
[TBL] [Abstract][Full Text] [Related]
6. Vaccinomic approach for novel multi epitopes vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Almofti YA; Abd-Elrahman KA; Eltilib EEM
BMC Immunol; 2021 Mar; 22(1):22. PubMed ID: 33765919
[TBL] [Abstract][Full Text] [Related]
7. Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysis.
Khairkhah N; Aghasadeghi MR; Namvar A; Bolhassani A
PLoS One; 2020; 15(10):e0240577. PubMed ID: 33057358
[TBL] [Abstract][Full Text] [Related]
8. Designing of cytotoxic T lymphocyte-based multi-epitope vaccine against SARS-CoV2: a reverse vaccinology approach.
Vivekanandam R; Rajagopalan K; Jeevanandam M; Ganesan H; Jagannathan V; Selvan Christyraj JD; Kalimuthu K; Selvan Christyraj JRS; Mohan M
J Biomol Struct Dyn; 2022; 40(24):13711-13726. PubMed ID: 34696708
[TBL] [Abstract][Full Text] [Related]
9. Immunoinformatic design of a COVID-19 subunit vaccine using entire structural immunogenic epitopes of SARS-CoV-2.
Behmard E; Soleymani B; Najafi A; Barzegari E
Sci Rep; 2020 Nov; 10(1):20864. PubMed ID: 33257716
[TBL] [Abstract][Full Text] [Related]
10. High throughput and comprehensive approach to develop multiepitope vaccine against minacious COVID-19.
Ojha R; Gupta N; Naik B; Singh S; Verma VK; Prusty D; Prajapati VK
Eur J Pharm Sci; 2020 Aug; 151():105375. PubMed ID: 32417398
[TBL] [Abstract][Full Text] [Related]
11. Multi-epitope vaccine against SARS-CoV-2 applying immunoinformatics and molecular dynamics simulation approaches.
Jyotisha ; Singh S; Qureshi IA
J Biomol Struct Dyn; 2022 Apr; 40(7):2917-2933. PubMed ID: 33164664
[TBL] [Abstract][Full Text] [Related]
12. A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2.
Jahangirian E; Jamal GA; Nouroozi M; Mohammadpour A
Immunogenetics; 2021 Dec; 73(6):459-477. PubMed ID: 34542663
[TBL] [Abstract][Full Text] [Related]
13. Exploring SARS-COV-2 structural proteins to design a multi-epitope vaccine using immunoinformatics approach: An in silico study.
Sanami S; Alizadeh M; Nosrati M; Dehkordi KA; Azadegan-Dehkordi F; Tahmasebian S; Nosrati H; Arjmand MH; Ghasemi-Dehnoo M; Rafiei A; Bagheri N
Comput Biol Med; 2021 Jun; 133():104390. PubMed ID: 33895459
[TBL] [Abstract][Full Text] [Related]
14. Proteome based analysis of circulating SARS-CoV-2 variants: approach to a universal vaccine candidate.
Oladipo EK; Ojo TO; Olufemi SE; Irewolede BA; Adediran DA; Abiala AG; Hezekiah OS; Idowu AF; Oladeji YG; Ikuomola MO; Olayinka AT; Akanbi GO; Idowu UA; Olubodun OA; Odunlami FD; Ogunniran JA; Akinro OP; Adegoke HM; Folakanmi EO; Usman TA; Oladokun EF; Oluwasanya GJ; Awobiyi HO; Oluwasegun JA; Akintibubo SA; Jimah EM
Genes Genomics; 2023 Dec; 45(12):1489-1508. PubMed ID: 37548884
[TBL] [Abstract][Full Text] [Related]
15. Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant.
Khan K; Khan SA; Jalal K; Ul-Haq Z; Uddin R
Virology; 2022 Jul; 572():28-43. PubMed ID: 35576833
[TBL] [Abstract][Full Text] [Related]
16. An in-depth in silico and immunoinformatics approach for designing a potential multi-epitope construct for the effective development of vaccine to combat against SARS-CoV-2 encompassing variants of concern and interest.
Saba AA; Adiba M; Saha P; Hosen MI; Chakraborty S; Nabi AHMN
Comput Biol Med; 2021 Sep; 136():104703. PubMed ID: 34352457
[TBL] [Abstract][Full Text] [Related]
17. Developing a multiepitope vaccine for the prevention of SARS-CoV-2 and monkeypox virus co-infection: A reverse vaccinology analysis.
Jiang F; Liu Y; Xue Y; Cheng P; Wang J; Lian J; Gong W
Int Immunopharmacol; 2023 Feb; 115():109728. PubMed ID: 36652758
[TBL] [Abstract][Full Text] [Related]
18. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.
Uttamrao PP; Sathyaseelan C; Patro LPP; Rathinavelan T
Front Immunol; 2021; 12():692937. PubMed ID: 34497604
[TBL] [Abstract][Full Text] [Related]
19. Excavating SARS-coronavirus 2 genome for epitope-based subunit vaccine synthesis using immunoinformatics approach.
Chauhan V; Rungta T; Rawat M; Goyal K; Gupta Y; Singh MP
J Cell Physiol; 2021 Feb; 236(2):1131-1147. PubMed ID: 32643158
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T-lymphocyte elicited vaccine against SARS-CoV-2 employing immunoinformatics framework.
Kumar N; Admane N; Kumari A; Sood D; Grover S; Prajapati VK; Chandra R; Grover A
Sci Rep; 2021 Apr; 11(1):7653. PubMed ID: 33828130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]